Package 69367-272-16

{"route": ["ORAL"], "spl_id": "82e575e8-9a6e-432e-8991-8f640de01dd6", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "upc": ["0369367272162"], "unii": ["GSL05Y1MN6", "495W7451VQ"], "rxcui": ["995868"], "spl_set_id": ["3da3efd7-e278-4d79-9130-eef3992097e4"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Westminster Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "118 mL in 1 BOTTLE (69367-272-04)", "package_ndc": "69367-272-04", "marketing_start_date": "20200715"}, {"sample": false, "description": "473 mL in 1 BOTTLE (69367-272-16)", "package_ndc": "69367-272-16", "marketing_start_date": "20200715"}], "brand_name": "Codeine-Guaifenesin", "product_id": "69367-272_82e575e8-9a6e-432e-8991-8f640de01dd6", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Full Opioid Agonists [MoA]", "Increased Respiratory Secretions [PE]", "Opioid Agonist [EPC]"], "product_ndc": "69367-272", "dea_schedule": "CV", "generic_name": "Codeine Phosphate and Guaifenesin", "labeler_name": "Westminster Pharmaceuticals, LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Codeine-Guaifenesin", "active_ingredients": [{"name": "CODEINE PHOSPHATE", "strength": "10 mg/5mL"}, {"name": "GUAIFENESIN", "strength": "100 mg/5mL"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20200715", "listing_expiration_date": "20261231"}